Pain Relief Liquid

Description

Personal Care Solutions offers a maximum strength pain relief liquid designed for effective and long-lasting relief. This formulation features a powerful, fast-acting formula that penetrates deeply and dries quickly. The product is packaged in a 2.5 fl. oz. (73 ml) container and utilizes a no-mess roll-on applicator, ensuring that the roller ball keeps hands clean during application.

Uses and Indications

This drug is indicated for the temporary relief of minor pain associated with various conditions, including arthritis, simple backache, muscle strains, sprains, bruises, and cramps.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children over 12 years of age should apply the medication generously to the affected area. It is important to massage the formulation into the painful area until it is thoroughly absorbed into the skin. This application may be repeated as necessary, but should not exceed 3 to 4 times daily.

Contraindications

There are no specific contraindications identified for this product. However, it is advised to discontinue use and consult a healthcare professional if any of the following occur: worsening of the condition, presence of redness, development of irritation, or if symptoms persist for more than 7 days or resolve and then recur within a few days.

Warnings and Precautions

For external use only. This product should be utilized strictly as directed. It is imperative to avoid bandaging the area tightly or using it in conjunction with a heating pad. Contact with eyes and mucous membranes must be avoided to prevent irritation. The product should not be applied to wounds or any damaged, broken, or irritated skin.

Users may experience a transient burning sensation upon application; however, this typically resolves within several days. Should a severe burning sensation occur, the use of the product must be discontinued immediately. Additionally, the treated area should not be exposed to heat or direct sunlight to prevent adverse reactions.

This product is flammable; therefore, it should be kept away from fire or flame to mitigate the risk of ignition. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should advise patients to stop using the product and consult a physician if any of the following occur: worsening of the condition, presence of redness, development of irritation, or if symptoms persist for more than 7 days or resolve only to recur within a few days. Regular monitoring of the patient's response to treatment is recommended to ensure safety and efficacy.

Side Effects

Patients may experience a transient burning sensation upon application of the product, which typically resolves within several days. However, if a severe burning sensation occurs, it is advised to discontinue use immediately.

In the event of worsening conditions, the presence of redness, the development of irritation, or if symptoms persist for more than 7 days or resolve only to recur within a few days, patients should stop use and consult a healthcare professional.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Pain Relief Liquid (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients 12 years of age or younger should consult a healthcare professional before use. It is important to assess the appropriateness of treatment and dosage for this age group, as specific recommendations may vary based on individual health needs and conditions.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Supportive care is the cornerstone of management, which may involve maintaining airway patency, providing supplemental oxygen, and ensuring hemodynamic stability.

Healthcare professionals should also consider contacting a poison control center for guidance on specific interventions and antidotes that may be appropriate based on the clinical scenario. Continuous monitoring and supportive measures should be implemented until the patient is stabilized and any potential complications are addressed.

Documentation of the incident, including the substance involved, estimated dose, time of exposure, and any symptoms observed, is crucial for ongoing management and future reference.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Patients should be instructed to discontinue use and consult a healthcare professional if any of the following occur: the condition worsens, redness appears, irritation develops, or if symptoms persist for more than 7 days or resolve only to recur within a few days. It is important for patients to be aware of these signs and to take appropriate action to ensure their safety and well-being.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, ensuring that it is kept away from fire or flame. Additionally, the area treated with the product should not be exposed to heat or direct sunlight to maintain its efficacy.

In the event that the medicine comes into contact with hands, it is advised to wash the affected area thoroughly with soap and water. Proper handling and storage conditions are crucial to ensure the product's integrity and safety.

Additional Clinical Information

The product is administered topically, with instructions for adults and children over 12 years to apply generously to the affected area and massage until fully absorbed. This application may be repeated as necessary, but should not exceed 3-4 times daily.

Clinicians should counsel patients to use the product only as directed, avoiding tight bandaging or the use of heating pads. Contact with eyes and mucous membranes should be avoided, and the product should not be applied to wounds or damaged skin. Patients may experience a transient burning sensation upon application, which typically resolves within several days; however, if a severe burning sensation occurs, use should be discontinued immediately. Additionally, treated areas should not be exposed to heat or direct sunlight. Pregnant or breastfeeding patients should consult a healthcare professional before use, and in the event of ingestion, medical assistance or contact with a Poison Control Center is advised.

Drug Information (PDF)

This file contains official product information for Pain Relief Liquid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)